K. F. Rafeifadattis, N. Rizkillah, N. N. Aulia, V. Apriani, and H. Sudarjat, “Empaglifozin In Type 2 Diabetes: From Mechanisms To Clinical Practice – A Comprehensive Review Of Monotherapy, Combinations, And Therapeutic Advantages”, JN, vol. 10, no. 1, pp. 182–195, Nov. 2025.